Erosive Esophagitis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study to Demonstrate the Maintenance Effect of Treatment and Confirm the Safety of DWP14012 in Patients With Healed Erosive Esophagitis Confirmed on EGD After Medication Treatment
Condition: Healed Erosive Esophagitis Interventions: Drug: DWP14012 X mg; Drug: DWP14012 Xmg placebo; Drug: Lansoprazole 15 mg; Drug: Lansoprazole 15 mg Placebo Sponsor: Daewoong Pharmaceutical Co. LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2020 Category: Research Source Type: clinical trials
Study to Demonstrate the Maintenance Effect of Treatment and Confirm the Safety of DWP14012 in Patients With Healed Erosive Esophagitis
Condition: Healed Erosive Esophagitis Interventions: Drug: DWP14012 X mg; Drug: DWP14012 Xmg placebo; Drug: Lansoprazole 15 mg; Drug: Lansoprazole 15 mg Placebo Sponsor: Daewoong Pharmaceutical Co. LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2020 Category: Research Source Type: clinical trials
Study to Demonstrate the Maintenance Effect of Treatment and Confirm the Safety of DWP14012 in Patients With Healed Erosive Esophagitis Confirmed on EGD After Medication Treatment
Condition: Healed Erosive Esophagitis Interventions: Drug: DWP14012 X mg; Drug: DWP14012 Xmg placebo; Drug: Lansoprazole 15 mg; Drug: Lansoprazole 15 mg Placebo Sponsor: Daewoong Pharmaceutical Co. LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2020 Category: Research Source Type: clinical trials
Study to Demonstrate the Maintenance Effect of Treatment and Confirm the Safety of DWP14012 in Patients With Healed Erosive Esophagitis
Condition: Healed Erosive Esophagitis Interventions: Drug: DWP14012 X mg; Drug: DWP14012 Xmg placebo; Drug: Lansoprazole 15 mg; Drug: Lansoprazole 15 mg Placebo Sponsor: Daewoong Pharmaceutical Co. LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2020 Category: Research Source Type: clinical trials
Study to Demonstrate the Maintenance Effect of Treatment and Confirm the Safety of DWP14012 in Patients With Healed Erosive Esophagitis Confirmed on EGD After Medication Treatment
Condition: Healed Erosive Esophagitis Interventions: Drug: DWP14012 X mg; Drug: DWP14012 Xmg placebo; Drug: Lansoprazole 15 mg; Drug: Lansoprazole 15 mg Placebo Sponsor: Daewoong Pharmaceutical Co. LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2020 Category: Research Source Type: clinical trials
